luspatercept
bms
['lusp', 'mds']
congress #eha2023 | presents tx patterns &amp;transfusion outcomes in lr #mds pts treated with luspatercept in clinical practice. ntd was maintained in 95.2% pts while tb was reduced in 90.9% &amp; ti was achieved in 86.6% pts within 1-24 wks of tx
#mdssm 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm